Study: Quality of online health information varies

The quality of health information individuals discover from online searches varies significantly depending on what is asked and the results could be hazardous to one’s health, according to a University of Florida (UF) study.

Web searches related to the diagnosis and treatment of physical disease or injuries tend to yield higher-quality information than online searches for preventive health and social health information, according to the study in Decision Support Systems.

UF researchers queried Google’s general search engine using more than 2,000 different health-related terms. Then they looked at the first page of search results to see if they were certified for accuracy by the nonprofit Health on the Net Foundation or were included in Medline Plus, a consumer website run by the National Institutes of Health.

Researchers found, for example, that a search for the word “health” returned highly ranked results from reputable healthcare providers, but a search for “newborn vaccines” yielded hits for blogs and forums that discuss delaying or refusing medically recommended vaccinations.

“Inaccurate or misleading results could lead people to ignore important symptoms and delay or even refuse recommended healthcare,” Brent Kitchens, the study’s lead author and a doctoral candidate at the UF Warrington College of Business Administration’s department of information systems and operations management, said in a release. “Low-quality results could also lead people to seek unnecessary healthcare or implement unproven or potentially harmful at-home treatments.”

Given these findings, the authors suggested that existing online resources should be examined for quality, and that healthcare and government organizations should disseminate more high-quality information on topics where accurate information is lacking.

Read the study here.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.